The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance
Authors:
- Francisco LlorenteFrancisco Llorente
- Elisa Pérez-RamírezEPElisa Pérez-Ramírez
- Mayte Pérez-OlmedaMayte Pérez-Olmeda
- Desirée Dafouz-BustosDDDesirée Dafouz-Bustos
- Jovita Fernández-PineroJFJovita Fernández-Pinero
- Mercedes Martínez-CortésMMMercedes Martínez-Cortés
- Miguel Ángel Jiménez-ClaveroMiguel Ángel Jiménez-Clavero
Open Access
- 16 November 2023
- Vol. 12 (11) , 1360
Abstract
The presence of SARS-CoV-2 antibodies was examined over 7 months in a population of essential service workers exposed during the first epidemic wave in Madrid (Spain). Results obtained with different serological assays were compared. Firstly, serum samples obtained in April 2020 were analyzed using eleven SARS-CoV-2 antibody detection methods, including seven ELISAs, two CLIAs and two LFAs. While all of the ELISA tests and the Roche eCLIA method showed good performance, it was poorer for the Abbott CLIA and LFA tests. Sera from 115 workers with serologically positive results in April were collected 2 and 7 months after the first sampling and were analyzed using five of the tests previously assessed. The results showed that while some ELISA tests consistently detected the presence of anti-SARS-CoV-2 antibodies even 7 months after first detection, other methods, such as the Abbott CLIA test, showed an important reduction in sensitivity for these mature antibodies. The sensitivity increased after establishing new cut-off values, calculated taking into account both recent and old infections, suggesting that an adjustment of assay parameters may improve the detection of individuals exposed to the infection.Keywords
Funding Information
- Madrid City Council (Specific epidemiological and health studies of COVID-19 to know the prevalence of the disease in essential operational sectors)
This publication has 27 references indexed in Scilit:
- Assay dependence of long-term kinetics of SARS-CoV-2 antibodiesDiagnostic Microbiology and Infectious Disease, 2021
- Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune responseJournal of Immunological Methods, 2021
- Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodiesJournal of Virological Methods, 2021
- Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workersJournal of Infection, 2021
- Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based studyClinical Microbiology and Infection, 2021
- Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after InfectionMicroorganisms, 2021
- Evaluating 10 Commercially Available SARS-CoV-2 Rapid Serological Tests by Use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) MethodJournal of Clinical Microbiology, 2021
- Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care testDiagnostic Microbiology and Infectious Disease, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977